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acid) resulted more active as a chondroprotector. The GR 375 
and GR 377, which are respectively the N,N-diethyl and diphene- 
tidin 2,6 disulfonamide derivatives of GR 373, are more active on 
bone. In this research we investigate the effect of GR 375 and GR 
377 on trabecular and subchondral bone in experimental animal. 
Methods: 18 female Wistar rats having a body weigth of 1804-10 
g were subjected to an experimentally-induced osteoporosis by 
surgically removing the ovaries. The animals were divided into 
three groups as follows: 1) control, 2) treated with GR 375 25 
mg/kg/os and 3) treated with GR 377 at the same dosage. Af- 
ter a three-month treatment period the rats were sacrificed and 
their posterior legs removed and stored in formalin solution at pH 
7.2. They were then dehydrated with warm methyl alcohol under 
vacuum and methyl methacrylate mbedded. Frontal 100 and 20- 
30 i~m thick sections of the specimens were prepared to evalu- 
ate the effect of treatment. Microradiographs of the femoral head 
and neck region were taken. The trabecular bone volume (%TBV) 
was measured histologically. The results indicate the treated an- 
imals (GR 377:54.53 4- 7.37, GR 375:49.48 4- 9.97) to have 
a greater %TBV when compared to the control group (41.32 4- 
4.54), nonetheless statistical significance was obtained only for 
the GR 377 treated group. Similar results were obtained after 
having assessed the tibial trabecular thickness. The subchondral 
and cortical components of bone were also markedly increased 
in the treated animals when compared to their control counter- 
parts.Bone density and mineralization are statistically higher in 
treated animals. 
Conclusion: 2,6 diphenetidine anthraquinone disulphonamide 
(GR 377) has been shown to be effective in increasing bone 
mass in the trabecular, subchondral and cortical components of 
bone in the ovariectomized rat. N,N' diethyl 2,6 anthraquinone 
disulphonamide (GR 375) was also shown to be effective, al- 
though not to the same extent as that of GR 377. Other studies 
have demonstrated these compounds to significantly decrease 
IL-6 and iNOS in LPS-challenged rats and to modulate the ex- 
pression of some proteins in bone metabolism and mineraliza- 
tion. The data suggest that one mechanism of GR 377 and GR 
375 action is the modulation of bone gene expression. 
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ORAL ADMINISTRATION OF ANABU TM (GIcNBu) TO 
OVARIECTOMIZED (OVX) RATS INCREASES BONE 
MINERAL DENSITY (BMD), LONG BONE GROWTH AND 
MODULATES GENE EXPRESSION IN THE LIVER 
TP Anastassiades X Yang, J Carran, K Rees-Milton, D Wainman 
Medicine, Queen's Universi~ Kingston, ON, Canada 
In previous studies, we had shown increased BMD in the long 
bones of an inlammatory arthritis model in the rat, by feeding 
GIcNBu (N-butyryl glucosamine). The aim of this study is to deter- 
mine if oral admininistration of GIcNBu affects BMD, bone growth 
and gene expression in the non-OVX and the OVX-rat model. 
Female Sprague Dawley rats were randomized into four Groups 
(8 animals each). In addition to their normal diet, the animals 
were fed on a daily basis (once a day), with either of GIcNBu 200 
mg/kg, or an equimolar amount of glucose (GIc) for 6 months. 
Groups 1,2, 3 and 4 were, respectively: GIc-fed, non-OVX, (Con- 
trol); GIcNBu-fed, non-OVX; GIc-fed, OVX; GIcNBu-fed, OVX. 
The BMD and body composition was measured by DXA (Ho- 
logic 4500, small animal software) every 2 months. At sacrifice (6 
months), femurs were removed for physical measurements. The 
total RNA from the liver was extracted (RNeasy Kit, Qiagen) and 
gene expression was assessed by microarray (rat 8K gene, flu- 
orescent Cy3 and Cy5), with Group 1 serving as the control for 
each of Groups 2-4. 
The results showed that there was increased length of femurs 
for Group 4 vs 3 and in femoral wet weights (trends), as well as 
for Group 2 vs 1 (Fig. 1). As expected, OVX led to increased 
body mass. The BMD of Group 4 femoral heads were higher than 
Group 3. Total body mineral content + lean body mass was also 
highest in Group 4. 
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Fig. 1. Effect of GIcNBu on femoral length (OVX and Controls). 
By microarray (all compared to Group 1), the number of regu- 
lated genes (> 2-fold) in the liver were: Group 2, 13; Group 3, 40; 
Group 4, 57. A small number of genes were highly regulated only 
in Group 3. 
We conclude that oral administration of GIcNBu results in en- 
hanced growth and increased BMD of femurs in the OVX rat. The 
microarray analysis (rat 8K gene chip) showed that a number of 
genes in the liver were remarkably regulated by GIcNBu. Compar- 
isons of the 4 experimental Groups suggest that GIcNBu feeding 
selectively regulates some genes post-ovariectomy. Since some 
of the selectively up-regulated genes in Group 4 encode for ciru- 
lating protein growth factors, we speculate that this may constitute 
a mechanism of action for the effects of GIcNBu on bone. 
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TRANSPORTERS (GLUTs) IN NORMAL AND 
DEGENERATE HUMAN INTERVERTEBRAL DISCS 
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Aim of Study: Tissues such as cartilage and the intervertebral 
disc (IVD) are hypoxic and avascular and this affects glycolysis 
and cell metabolism. We have recently shown that human chon- 
drocytes express the hypoxia-inducible transcription factor alpha 
(H IF-1 ~), along with a number of facilitative glucose transporters 
including GLUT1, GLUT3 and GLUT9. Other groups have shown 
that cells from the rat nucleus pulposus (NP) express both GLUT1 
and H IF-1 ~, yet to date, no studies have identified the expression 
of HIF-I~ or other GLUTs in the human intervertebral disc. In this 
study we have used immunohistochemistry (IHC) to examine the 
expression of HIF-I~, GLUT1, GLUT3 and GLUT9 in normal and 
degenerate IVDs. 
Methods: Thirty-one paraffin-embedded human intervertebral 
disc biopsies were chosen for analysis. These included 10 non- 
degenerate and 21 degenerate discs. IHC was conducted using 
antibodies against HIF-I~, GLUT1, GLUT3 and GLUT9 and hu- 
man tissue microarrays erved as positive controls. 
Results: IHC confirmed that HIF-I~ and GLUTs 1, 3 and 9 pro- 
teins were all expressed in the normal human IVD. Expression 
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was found to be highest in the NP, then the inner annulus fibro- 
sus, with only low levels in the outer AE Expression was also 
found to alter with stage of degeneration. 
Conclusion: We have shown for the first time that normal hu- 
man intervertebral discs express HIF-1 ~ and a range of hypoxia- 
responsive GLUTs and that the level of expression is dependant 
on disc region. Furthermore we have demonstrated that their ex- 
pression is altered during IVD degeneration. These findings have 
implications for understanding the phenotype of cells within var- 
ious regions of the IVD and the metabolic processes occurring 
during degeneration. 
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EFFECT OF AMINO ACIDS ADDED TO THE CULTURE 
MEDIUM ON COLLAGEN BIOSYNTHESIS BY 
CHONDROCYTES CULTURED IN VITRO 
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1 Dept. Biochemistry & Molecular Biology, University of La 
Laguna, La Laguna, Tenerife, Spain; 2Institute of Ceflular 
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Aim of study: To investigate the effect of several amino acids on 
type II collagen biosynthesis by articular chondrocytes cultured in 
vitro. 
Methods: Articular chondrocytes were isolated aseptically from 
the cartilage of bovine interphalangeal joints by collagenase di- 
gestion. Cells were seeded at high density in 24-well culture 
plates and incubated at 37°C in a 5% CO2 atmosphere. After 
24 hours, basal medium (Ham F12 containing 10% FBS) was re- 
placed by Ham F12 supplemented with different concentrations 
of glycine, proline or lysine: 0.025; 0.05; 0.1; 0.5; 1; 5 and 10 
mg/mL. The cells were incubated for a further 12 days with the 
supplemented media. At the end of the stimulation period, on cul- 
ture day 13 th, the amount of type II collagen secreted by the cells 
was quantified by means of an ELISA technique. Chondrocytes 
in the control group were maintained in the basal medium for 13 
days. All results are expressed as mean values 4- SD. The sig- 
nificance of differences between treated groups and untreated 
controls was calculated using the two tailed Student's t test. 
Results: As Fig. 1 shows, the treatment of cultured chondrocytes 
with glycine, proline or lysine over a culture period of 13 days 
leads to a dose-dependent increase in type II collagen secretion; 
although too high concentrations of these amino acids induce 
a decreased in collagen production. Optimum concentration of 
glycine seems to be 0.05 mg/mL, although concentrations in the 
range of 0.025-1 mg/mL also induce a significant rise in collagen 
synthesis. Proline also stimulates collagen secretion, mainly in a 
concentration range of 0.05 to 0.5 mg/mL. And a small amount of 
lysine (0.025-0.1 mg/mL) produces a two-fold increase in colla- 
gen production, although the highest dosages of this amino acid 
lead to a decrease in cell growth and collagen biosynthesis. 
Conclusions: Our results indicate that the addition of glycine, 
proline or lysine to the culture medium stimulates type II colla- 
gen secretion by articular chondrocytes. This could be of spe- 
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cial therapeutic significance in the treatment of degenerative 
joint diseases such as osteoarthritis. Since decreased collagen 
metabolism seems to be an important factor for the progression 
of this disease, it might be reasonable to utilize these amino acids 
as nutritional supplements to activate collagen biosynthesis in ar- 
ticular cartilage. 
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CHONDROITIN SULFATE UP-REGULATES THE 
EXPRESSION OF THE AGGRECAN CORE PROTEIN AND 
INHIBITS THAT OF IL-11~ INDUCED MATRIX 
PROTEINASES AND INFLAMMATORY MEDIATORS 
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Aim: To determine the effect of pharmacologically relevant con- 
centrations of avian chondroitin sulfate (CS) on the regulation of 
IL-1 induced gene expression in articular chondrocytes cultured 
in three-dimensional gel and low oxygen tension. 
Methods: Bovine articular chondrocytes were cultured in algi- 
nate beads and hypoxic atmosphere (5% O2), using DMEM+I 0% 
FCS previously conditionned to 5% 02 by gas bubbling. After 8 
days, the beads were incubated with medium containing avian CS 
(MW: 4-18 Kda) and medium changes were done every 2-3 days. 
6 or 7 days later, IL-11~ (10 ng/ml) was added to some flasks for 24 
or 48 h. At the end of experiment (day 15th), the beads were dis- 
solved in Na Citrate/EDTA solution and the cells were collected. 
RNA was isolated and reverse transcribed to cDNA, which was 
then subjected to the relative quantitative real-time PCR (Q-RT- 
PCR) procedure, using the ABI PRISM 7000 and SYBR green 
detection and specific primers for type II collagen, aggrecan core 
protein, MMP-1, -3, -13, aggrecanases 1 and 2, COX-1 and COX- 
2, and iNOS. RT-PCR data were normalized with 18S RNA and 
gene expression relative to control was calculated with the delta 
delta cycle to threshold (ddCt) method. Radiolabeling with 35S- 
sulfate (3 i~Ci/ml) was also performed to assay GAG neosynthe- 
sis. 
Results: CS did not have significant effect on basal and IL-1 in- 
duced levels of type II collagen mRNA. In contrast, 10 i~g/ml CS 
was found to increase aggrecan core protein expression in nor- 
mal chondrocytes and 10-100 i~g/ml CS repressed the IL-1 in- 
duced inhibition of the gene (24 and 48 h). The up-regulation of 
MMP-1, -3, -13, aggrecanases-1 and -2 by IL-1 (24 or 48 h, de- 
pending on the gene) was also reduced by previous incubation 
with 10 and 100 i~g/ml CS. Similarly, the IL-l-enhanced COX-l, 
COX-2, and iNOS mRNA levels were decreased by pretreatment 
with 10 and 100 i~g/ml CS. 
Conclusions: Avian CS exerts anabolic effects on PG synthesis 
and represses the IL-1 stimulated matrix proteinases gene ex- 
pression in articular chondrocytes cultured in a system mimick- 
ing the in vivo celllular conditions. Furthermore, the agent can 
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